We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Indian government said Tuesday that it will lift its newly imposed export restriction on the anti-malaria drug hydroxychloroquine, a potential COVID-19 treatment. Read More
The European Medicines Agency yesterday announced a new system for reporting drug shortages and potential supply disruptions as the COVID-19 pandemic takes a toll on the stock of some critical medicines. Read More
President Trump has reached out to India’s Prime Minister Narendra Modi following India’s export freeze on the COVID-19 treatment hydroxychloroquine, calling for an exception to the country’s new restrictions. Read More
A coalition of more than 50 rheumatology and lupus organizations urged all 50 governors in a letter to ensure patient access to chloroquine and hydroxychloroquine, which are used to treat lupus and arthritis, as well as malaria and now COVID-19. Read More
A group representing the drug supply chain is strongly arguing that a proposed executive order to only supply drugs domestically could mean that Americans won’t have access to the drugs they need. Read More
Manufacturers need to provide two-week updates on any supply issues during the COVID-19 emergency and going forward, the FDA said in a new straight-to-final guidance. Read More
The FDA issued an emergency use authorization (EUA) for the anti-malaria drugs hydroxychloroquine sulfate and chloroquine phosphate, clearing the way for HHS to distribute millions of doses for COVID-19 patients. Read More
In another blow to Genentech’s blockbuster cancer drug Herceptin, a federal appeals court upheld the U.S. Patent Trial and Appeals Board’s invalidation of two patents it holds on the drug. Read More